ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gonadotropin-releasing Hormone Antagonists Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24G8599
Home | Market Reports | Health| Reproductive Health
Global Gonadotropin releasing Hormone Antagonists Market Outlook 2022
BUY CHAPTERS

Global Gonadotropin-releasing Hormone Antagonists Market Research Report 2025

Code: QYRE-Auto-24G8599
Report
July 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Takeda
Astellas
Kissei
Veru Inc.
Myovant Sciences
Astrazeneca plc
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co

Gonadotropin-releasing Hormone Antagonists Market

The global market for Gonadotropin-releasing Hormone Antagonists was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gonadotropin-releasing hormone antagonists are used to treat advanced prostate cancer. They are also used to treat certain gynecologic conditions and are being studied in the treatment of hormone-sensitive breast cancer. Also called GnRH antagonist, LHRH antagonist, and luteinizing hormone-releasing hormone antagonist.
North American market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Gonadotropin-releasing Hormone Antagonists include AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals, Jiangsu Hengrui Medicine Co, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gonadotropin-releasing Hormone Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonadotropin-releasing Hormone Antagonists.
The Gonadotropin-releasing Hormone Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gonadotropin-releasing Hormone Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonadotropin-releasing Hormone Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gonadotropin-releasing Hormone Antagonists Market Report

Report Metric Details
Report Name Gonadotropin-releasing Hormone Antagonists Market
Segment by Type
  • Peptides
  • Small Molecules
Segment by Application
  • Prostate Cancer
  • Endometriosis
  • Uterine Fibroids
  • Female Infertility
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals, Jiangsu Hengrui Medicine Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gonadotropin-releasing Hormone Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gonadotropin-releasing Hormone Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gonadotropin-releasing Hormone Antagonists Market report?

Ans: The main players in the Gonadotropin-releasing Hormone Antagonists Market are AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals, Jiangsu Hengrui Medicine Co

What are the Application segmentation covered in the Gonadotropin-releasing Hormone Antagonists Market report?

Ans: The Applications covered in the Gonadotropin-releasing Hormone Antagonists Market report are Prostate Cancer, Endometriosis, Uterine Fibroids, Female Infertility, Others

What are the Type segmentation covered in the Gonadotropin-releasing Hormone Antagonists Market report?

Ans: The Types covered in the Gonadotropin-releasing Hormone Antagonists Market report are Peptides, Small Molecules

1 Gonadotropin-releasing Hormone Antagonists Market Overview
1.1 Product Definition
1.2 Gonadotropin-releasing Hormone Antagonists by Type
1.2.1 Global Gonadotropin-releasing Hormone Antagonists Market Value Comparison by Type (2024 VS 2031)
1.2.2 Peptides
1.2.3 Small Molecules
1.3 Gonadotropin-releasing Hormone Antagonists by Application
1.3.1 Global Gonadotropin-releasing Hormone Antagonists Market Value by Application (2024 VS 2031)
1.3.2 Prostate Cancer
1.3.3 Endometriosis
1.3.4 Uterine Fibroids
1.3.5 Female Infertility
1.3.6 Others
1.4 Global Gonadotropin-releasing Hormone Antagonists Market Size Estimates and Forecasts
1.4.1 Global Gonadotropin-releasing Hormone Antagonists Revenue 2020-2031
1.4.2 Global Gonadotropin-releasing Hormone Antagonists Sales 2020-2031
1.4.3 Global Gonadotropin-releasing Hormone Antagonists Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gonadotropin-releasing Hormone Antagonists Market Competition by Manufacturers
2.1 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gonadotropin-releasing Hormone Antagonists Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gonadotropin-releasing Hormone Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Product Type & Application
2.7 Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Date of Enter into This Industry
2.8 Global Gonadotropin-releasing Hormone Antagonists Market Competitive Situation and Trends
2.8.1 Global Gonadotropin-releasing Hormone Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gonadotropin-releasing Hormone Antagonists Players Market Share by Revenue
2.8.3 Global Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gonadotropin-releasing Hormone Antagonists Market Scenario by Region
3.1 Global Gonadotropin-releasing Hormone Antagonists Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2020-2031
3.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2020-2025
3.2.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2026-2031
3.3 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2020-2031
3.3.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2020-2025
3.3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2026-2031
3.4 North America Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.4.1 North America Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2020-2031)
3.4.3 North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.5.1 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2020-2031)
3.5.3 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific Gonadotropin-releasing Hormone Antagonists Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region (2020-2031)
3.6.3 Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.7.1 Latin America Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2020-2031)
3.7.3 Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2020-2031)
4.1.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2020-2025)
4.1.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2026-2031)
4.1.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2020-2031)
4.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2020-2031)
4.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2020-2025)
4.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2026-2031)
4.2.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2020-2031)
4.3 Global Gonadotropin-releasing Hormone Antagonists Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2020-2031)
5.1.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2020-2025)
5.1.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2026-2031)
5.1.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2020-2031)
5.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2020-2031)
5.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2020-2025)
5.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2026-2031)
5.2.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2020-2031)
5.3 Global Gonadotropin-releasing Hormone Antagonists Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Company Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Astellas
6.3.1 Astellas Company Information
6.3.2 Astellas Description and Business Overview
6.3.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Astellas Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.3.5 Astellas Recent Developments/Updates
6.4 Kissei
6.4.1 Kissei Company Information
6.4.2 Kissei Description and Business Overview
6.4.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kissei Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.4.5 Kissei Recent Developments/Updates
6.5 Veru Inc
6.5.1 Veru Inc Company Information
6.5.2 Veru Inc Description and Business Overview
6.5.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.5.5 Veru Inc Recent Developments/Updates
6.6 Myovant Sciences
6.6.1 Myovant Sciences Company Information
6.6.2 Myovant Sciences Description and Business Overview
6.6.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.6.5 Myovant Sciences Recent Developments/Updates
6.7 AstraZeneca
6.7.1 AstraZeneca Company Information
6.7.2 AstraZeneca Description and Business Overview
6.7.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.7.4 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Ferring Pharmaceuticals
6.8.1 Ferring Pharmaceuticals Company Information
6.8.2 Ferring Pharmaceuticals Description and Business Overview
6.8.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.8.5 Ferring Pharmaceuticals Recent Developments/Updates
6.9 Jiangsu Hengrui Medicine Co
6.9.1 Jiangsu Hengrui Medicine Co Company Information
6.9.2 Jiangsu Hengrui Medicine Co Description and Business Overview
6.9.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Co Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gonadotropin-releasing Hormone Antagonists Industry Chain Analysis
7.2 Gonadotropin-releasing Hormone Antagonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gonadotropin-releasing Hormone Antagonists Production Mode & Process Analysis
7.4 Gonadotropin-releasing Hormone Antagonists Sales and Marketing
7.4.1 Gonadotropin-releasing Hormone Antagonists Sales Channels
7.4.2 Gonadotropin-releasing Hormone Antagonists Distributors
7.5 Gonadotropin-releasing Hormone Antagonists Customer Analysis
8 Gonadotropin-releasing Hormone Antagonists Market Dynamics
8.1 Gonadotropin-releasing Hormone Antagonists Industry Trends
8.2 Gonadotropin-releasing Hormone Antagonists Market Drivers
8.3 Gonadotropin-releasing Hormone Antagonists Market Challenges
8.4 Gonadotropin-releasing Hormone Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Takeda
Astellas
Kissei
Veru Inc.
Myovant Sciences
Astrazeneca plc
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
List of Tables
 Table 1. Global Gonadotropin-releasing Hormone Antagonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gonadotropin-releasing Hormone Antagonists Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gonadotropin-releasing Hormone Antagonists Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gonadotropin-releasing Hormone Antagonists Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gonadotropin-releasing Hormone Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Product Type & Application
 Table 12. Global Key Manufacturers of Gonadotropin-releasing Hormone Antagonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gonadotropin-releasing Hormone Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonadotropin-releasing Hormone Antagonists as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gonadotropin-releasing Hormone Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2020-2025)
 Table 19. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2026-2031)
 Table 21. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2020-2025)
 Table 23. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2026-2031)
 Table 25. North America Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gonadotropin-releasing Hormone Antagonists Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) by Type (2020-2025)
 Table 51. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) by Type (2026-2031)
 Table 52. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2020-2025)
 Table 53. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2026-2031)
 Table 54. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2020-2025)
 Table 57. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2026-2031)
 Table 58. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) by Application (2020-2025)
 Table 61. Global Gonadotropin-releasing Hormone Antagonists Sales (K Units) by Application (2026-2031)
 Table 62. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2020-2025)
 Table 63. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2026-2031)
 Table 64. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2020-2025)
 Table 67. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2026-2031)
 Table 68. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Gonadotropin-releasing Hormone Antagonists Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Takeda Company Information
 Table 76. Takeda Description and Business Overview
 Table 77. Takeda Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Takeda Gonadotropin-releasing Hormone Antagonists Product
 Table 79. Takeda Recent Developments/Updates
 Table 80. Astellas Company Information
 Table 81. Astellas Description and Business Overview
 Table 82. Astellas Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Astellas Gonadotropin-releasing Hormone Antagonists Product
 Table 84. Astellas Recent Developments/Updates
 Table 85. Kissei Company Information
 Table 86. Kissei Description and Business Overview
 Table 87. Kissei Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Kissei Gonadotropin-releasing Hormone Antagonists Product
 Table 89. Kissei Recent Developments/Updates
 Table 90. Veru Inc Company Information
 Table 91. Veru Inc Description and Business Overview
 Table 92. Veru Inc Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Veru Inc Gonadotropin-releasing Hormone Antagonists Product
 Table 94. Veru Inc Recent Developments/Updates
 Table 95. Myovant Sciences Company Information
 Table 96. Myovant Sciences Description and Business Overview
 Table 97. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product
 Table 99. Myovant Sciences Recent Developments/Updates
 Table 100. AstraZeneca Company Information
 Table 101. AstraZeneca Description and Business Overview
 Table 102. AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. AstraZeneca Gonadotropin-releasing Hormone Antagonists Product
 Table 104. AstraZeneca Recent Developments/Updates
 Table 105. Ferring Pharmaceuticals Company Information
 Table 106. Ferring Pharmaceuticals Description and Business Overview
 Table 107. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product
 Table 109. Ferring Pharmaceuticals Recent Developments/Updates
 Table 110. Jiangsu Hengrui Medicine Co Company Information
 Table 111. Jiangsu Hengrui Medicine Co Description and Business Overview
 Table 112. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product
 Table 114. Jiangsu Hengrui Medicine Co Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Gonadotropin-releasing Hormone Antagonists Distributors List
 Table 118. Gonadotropin-releasing Hormone Antagonists Customers List
 Table 119. Gonadotropin-releasing Hormone Antagonists Market Trends
 Table 120. Gonadotropin-releasing Hormone Antagonists Market Drivers
 Table 121. Gonadotropin-releasing Hormone Antagonists Market Challenges
 Table 122. Gonadotropin-releasing Hormone Antagonists Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gonadotropin-releasing Hormone Antagonists
 Figure 2. Global Gonadotropin-releasing Hormone Antagonists Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gonadotropin-releasing Hormone Antagonists Market Share by Type: 2024 & 2031
 Figure 4. Peptides Product Picture
 Figure 5. Small Molecules Product Picture
 Figure 6. Global Gonadotropin-releasing Hormone Antagonists Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gonadotropin-releasing Hormone Antagonists Market Share by Application: 2024 & 2031
 Figure 8. Prostate Cancer
 Figure 9. Endometriosis
 Figure 10. Uterine Fibroids
 Figure 11. Female Infertility
 Figure 12. Others
 Figure 13. Global Gonadotropin-releasing Hormone Antagonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Gonadotropin-releasing Hormone Antagonists Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Gonadotropin-releasing Hormone Antagonists Sales (2020-2031) & (K Units)
 Figure 16. Global Gonadotropin-releasing Hormone Antagonists Average Price (USD/Unit) & (2020-2031)
 Figure 17. Gonadotropin-releasing Hormone Antagonists Report Years Considered
 Figure 18. Gonadotropin-releasing Hormone Antagonists Sales Share by Manufacturers in 2024
 Figure 19. Global Gonadotropin-releasing Hormone Antagonists Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Gonadotropin-releasing Hormone Antagonists Players: Market Share by Revenue in Gonadotropin-releasing Hormone Antagonists in 2024
 Figure 21. Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Gonadotropin-releasing Hormone Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2020-2031)
 Figure 24. North America Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2020-2031)
 Figure 25. United States Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2020-2031)
 Figure 28. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2020-2031)
 Figure 36. China Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Gonadotropin-releasing Hormone Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Gonadotropin-releasing Hormone Antagonists by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Gonadotropin-releasing Hormone Antagonists by Type (2020-2031)
 Figure 57. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Gonadotropin-releasing Hormone Antagonists by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Gonadotropin-releasing Hormone Antagonists by Application (2020-2031)
 Figure 60. Global Gonadotropin-releasing Hormone Antagonists Price (USD/Unit) by Application (2020-2031)
 Figure 61. Gonadotropin-releasing Hormone Antagonists Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Leuprolide Market Research Report 2024
Gonadotropin releasing Hormone Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gonadotropin releasing Hormone Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GnRH Receptor Antagonists Market Research Report 2024
Global GnRH Agonist Market Research Report 2024
Global Luteinizing Hormone Releasing Antagonist Market Research Report 2024
Global Leuprorelin Drugs Market Research Report 2024
Global Gonadorelin Market Insights Forecast to 2030
Global GnRHa Peptide Drugs Market Research Report 2024
Luteinizing Hormone releasing Hormone Analogs Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cetrotide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral GnRH Drugs Market Research Report 2024
Global Hormone Releasing Agonists Market Research Report 2024
Luteinizing Hormone releasing Hormone Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GnRH Analogues Market Research Report 2024
Global Leuprorelin Acetate Market Insights Forecast to 2030
Global Elagolix Drugs Market Research Report 2024
Global Enanton Leucorin Acetate Market Research Report 2024
Goserelin Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Leuprorelin Acetate Microspheres for Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions